A new study published in the Journal of Urology Open Plus reveals that 7 saw palmetto products met the identity and potency standards to effectively address urinary tract symptoms associated with an enlarged prostate.
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
Biomea’s BMF-219 is an investigational irreversible covalent inhibitor of menin. Image credit: eamesBot / Shutterstock. Biomea Fusion’s stock is on the up after the company